The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Cardiac and Skeletal Muscle Defects in a Mouse Model of Human Barth Syndrome
Open accessAbstract
Barth syndrome is an X-linked genetic disorder caused by mutations in the tafazzin (taz) gene and characterized by dilated cardiomyopathy, exercise intolerance, chronic fatigue, delayed growth, and neutropenia. Tafazzin is a mitochondrial transacylase required for cardiolipin remodeling. Although tafazzin function has been studied in non-mammalian model organisms, mammalian genetic loss of function approaches have not been used. We examined the consequences of tafazzin knockdown on sarcomeric mitochondria and cardiac function in mice. Tafazzin knockdown resulted in a dramatic decrease of tetralinoleoyl cardiolipin in cardiac and skeletal muscles and accumulation of monolysocardiolipins and cardiolipin molecular species with aberrant acyl groups. Electron microscopy revealed pathological changes in mitochondria, myofibrils, and mitochondrion-associated membranes in skeletal and cardiac muscles. Echocardiography and magnetic resonance imaging revealed severe cardiac abnormalities, including left ventricular dilation, left ventricular mass reduction, and depression of fractional shortening and ejection fraction in tafazzin-deficient mice. Tafazzin knockdown mice provide the first mammalian model system for Barth syndrome in which the pathophysiological relationships between altered content of mitochondrial phospholipids, ultrastructural abnormalities, myocardial and mitochondrial dysfunction, and clinical outcome can be completely investigated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel X-linked gene, G4.5. is responsible for Barth syndrome
Bione, S., D'Adamo, P., Maestrini, E., Gedeon, A. K., Bolhuis, P. A., & Toniolo, D. (1996) · Nature Genetics · doi:10.1038/ng0496-385 · Cited by 755
Eggan, K., Akutsu, H., Loring, J., Jackson-Grusby, L., Klemm, M., Rideout, W. M., Yanagimachi, R., & Jaenisch, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101118898 · Cited by 613
Cardiolipin: a proton trap for oxidative phosphorylation
Haines, T. H., & Dencher, N. A. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03292-1 · Cited by 405
Cardiolipin provides an essential activating platform for caspase-8 on mitochondria
Gonzalvez, F., Schug, Z. T., Houtkooper, R. H., MacKenzie, E. D., Brooks, D. G., Wanders, R. J. A., Petit, P. X., Vaz, F. M., & Gottlieb, E. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803129 · Cited by 296
Self-citationKiebish, M. A., Han, X., Cheng, H., Chuang, J. H., & Seyfried, T. N. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800319-jlr200 · Cited by 293
Boncompagni, S., Rossi, A. E., Micaroni, M., Beznoussenko, G. V., Polishchuk, R. S., Dirksen, R. T., & Protasi, F. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0783 · Cited by 282
Molecular symmetry in mitochondrial cardiolipins
Schlame, M., Ren, M., Xu, Y., Greenberg, M. L., & Haller, I. (2005) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2005.08.002 · Cited by 278
Coassembly of Mgm1 isoforms requires cardiolipin and mediates mitochondrial inner membrane fusion
DeVay, R. M., Dominguez-Ramirez, L., Lackner, L. L., Hoppins, S., Stahlberg, H., & Nunnari, J. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200906098 · Cited by 278
Kelley, R. I., Cheatham, J. P., Clark, B. J., Nigro, M. A., Powell, B. R., Sherwood, G., Sladky, J. T., & Swisher, W. P. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80289-6 · Cited by 272
Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure
Sparagna, G. C., Chicco, A. J., Murphy, R. C., Bristow, M. R., Johnson, C. A., Rees, M. L., Maxey, M. L., McCune, S. A., & Moore, R. L. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m600551-jlr200 · Cited by 262
Cited by
Hishikawa, D., Hashidate, T., Shimizu, T., & Shindou, H. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046094 · Cited by 434
Clarke, S. L., Bowron, A., Gonzalez, I. L., Groves, S. J., Newbury-Ecob, R., Clayton, N., Martin, R. P., Tsai-Goodman, B., Garratt, V., Ashworth, M., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-23 · Cited by 362
Self-citationThe complexity of cardiolipin in health and disease
Claypool, S. M., & Koehler, C. M. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.09.003 · Cited by 345
Metabolism and function of mitochondrial cardiolipin
Ren, M., Phoon, C. K. L., & Schlame, M. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.04.001 · Cited by 313
Cardiolipin, Mitochondria, and Neurological Disease
Falabella, M., Vernon, H. J., Hanna, M. G., Claypool, S. M., & Pitceathly, R. D. S. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.01.006 · Cited by 282
Metadata
- Authors
- Acehan, D., Vaz, F., Houtkooper, R. H., James, J., Moore, V., Tokunaga, C., Kulik, W., Wansapura, J., Toth, M. J., Strauss, A., & Khuchua, Z.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 286
- Issue
- 2
- Pages
- 899-908
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2144207859
- Cited by
- 259
- References
- 49
- FWCI
- 5.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cardiac and Skeletal Muscle Defects in a Mouse Model of Human Barth Syndrome. https://app.cochat.ai/papers/10.1074/jbc.m110.171439
- The paper
- Acehan, D., Vaz, F., Houtkooper, R. H., James, J., Moore, V., Tokunaga, C., Kulik, W., Wansapura, J., Toth, M. J., Strauss, A., & Khuchua, Z. (2011). Cardiac and Skeletal Muscle Defects in a Mouse Model of Human Barth Syndrome. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m110.171439
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.